Condition: Sustained VT · Sponsor: Adagio Medical
The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio VT Cryoablation System in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)
This description comes directly from the study's public registry record.
Nabil Jubran · 949 348 1188 · njubran@adagiomedical.com
Doug Kurschinski · dkurschinski@adagiomedical.com
Always discuss trial participation with your own doctor first.
| Banner University Medical Center Phoenix | Phoenix, Arizona, United States | Recruiting |
| University of California San Francisco | San Francisco, California, United States | Recruiting |
| Johns Hopkins University | Baltimore, Maryland, United States | Recruiting |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Icahn School of Medicine at Mount Sinai | New York, New York, United States | Recruiting |
| Weill Cornell Medical Center | New York, New York, United States | Recruiting |
| Northwell Health- Staten Island University Hospital | Staten Island, New York, United States | Recruiting |
| Ohio State University | Columbus, Ohio, United States | Recruiting |
| Hospital of University of Pennsylvania | Philadelphia, Pennsylvania, United States | Recruiting |
| Medical Center of South Carolina (MUSC) | Charleston, South Carolina, United States | Recruiting |
| Vanderbilt University Medical Center | Nashville, Tennessee, United States | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05675865